EXTRAOSSEOUS CALCIFICATION IN PATIENTS WITH CHRONIC KIDNEY DISEASE


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The paper considers the classification, epidemiology, pathophysiology, diagnosis of extraosseous calcification, and its complications in chronic kidney disease, as well as basic patient management strategies.

Full Text

Restricted Access

About the authors

G. Volgina

Moscow State University of Medicine and Dentistry

Email: VolginaGV@mail.ru

D. Seleznev

2OOO «Amdzhen»

O. Balkarova

City Clinical Hospital Twenty-Four

E. Lovchinsky

War Veterans Hospital Two

References

  1. Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group // Kidney Int. - 2009; 76 (Suppl. 113): S1-S130.
  2. Russo D., Palmiero G., De Blasio A. et al. Coronary artery calcification in patients with CRF not undergoing dialysis // Am. J. Kidney Dis. - 2004; 44: 1024-30.
  3. Spiegel D., Raggi P., Mehta R. et al. Coronary artery calcifications in patients new to dialysis // Hemodial. Int. - 2004; 8: 265-72.
  4. Raggi P., Boulay A., Chasan-Taber S. et al. Cardiac calcification in adult hemodialysis patients: a link between end-stage renal disease and cardiovascular disease // J. Am. Col.l Cardiol. - 2002; 39: 695-701.
  5. Kalpakian M., Mehrotra R. Vascular calcification and disordered mineral metabolism in dialysis patients // Semin Dial. - 2007; 20: 139-43.
  6. Ribeiro S., Ramos A., Brandao A. et al. Cardiac valve calcification in haemodialysis patients: role of calcium-phosphate metabolism // Nephrol. Dial. Transplant. - 1998; 13: 2037-40.
  7. Milas M., Weber C.J. Near-total parathyroidectomy is beneficial for patients with secondary and tertiary hyperparathyroidism // Surgery. - 2004; 136: 1252-60.
  8. Virchow R. Kalk-Metastasen // Virchows Arch. Pathol. Anat.- 1855; 8: 103-113.
  9. Giachelli C. Vascular Calcification Mechanisms // J. Am. Soc. Nephrol. -2004; 15: 2959-64.
  10. London G., Guerin A., Marchais S. et al. Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality // Nephrol. Dial. Transplant.- 2003; 18: 1731-40.
  11. Kendrick J., Chonchol M. The role of phosphorus in the development and progression of vascular calcification // Am. J. Kidney Dis. - 2011; 58: 826-34.
  12. Adeney K., Siscovick D., Ix J. et al. Association of serum phosphate with vascular and valvular calcification in moderate CKD // JASN. - 2009; 20: 381-7.
  13. Coen G., Manni M., Mantella D. et al. Are PTH serum levels predictive of coronary calcifications in haemodialysis patients? // Nephrol. Dial. Transplant. -2007; 22: 3262-7.
  14. Danziger J. Vitamin K-dependent proteins, warfarin, and vascular calcification // CJASN. -2008; 3:1504-10.
  15. Giachelli C. Vascular calcification mechanisms // J. Am. Soc. Nephrol. -2004; 15: 2959-64.
  16. de Francisco A., Kim D., Anker S. et al. An epidemiological study of hemodialysis patients based on the European Fresenius Medical Care hemodialysis network: results of the ARO study // Nephron. Clin. Pract. - 2011; 118: 143-54.
  17. US Renal Data System. USRDS 2011 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. - 2011.
  18. Taddei S., Nami R., Bruno R. et al. Hypertension, left ventricular hypertrophy and chronic kidney disease // Heart Fail. Rev. - 2011; 16: 615-20.
  19. McEniery C., McDonnell B., So A. et al. Aortic calcification is associated with aortic stiffness and isolated systolic hypertension in healthy individuals // Hypertension. - 2009; 53: 524-31.
  20. Raggi P., Bellasi A., Gamboa C. et al. All-cause Mortality in Hemodialysis Patients with Heart Valve Calcification // CJASN. - 2011; 6: 1990-5.
  21. Schlieper G., Kruger T. Djuric Z. et al. Vascular access calcification predicts mortality in hemodialysis patients // Kidney International. - 2008; 74: 1582-7.
  22. Verbeke M. et al. Prognostic Value of Aortic Stiffness and Calcification for Cardiovascular Events and Mortality in Dialysis Patients: Outcome of the Calcification Outcome in Renal Disease (CORD) Study // CJASN. - 2010; 1 (7): 153-9.
  23. Goldsmith D. et al. Endorsement of the Kidney Disease Improving Global Outcomes (KDIGO) Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guidelines: a European Renal Best Practice (ERBP) commentary statement // Nephrol. Dial. Transplant. - 2010; 25: 3823-31.
  24. Russo D., Miranda I., Ruocco C. et al. The Progression of Coronary Artery Calcification in Predialysis Patients on Calcium Carbonate or Sevelamer // Kidney Int. - 2007; 72 (10): 1255-61.
  25. Phan O., Ivanovski O., Nguyen-Khoa T. et al. Sevelamer prevents uremia-enhanced atherosclerosis progression in apolipoprotein E-deficient mice // Circulation. - 2005; 112: 2875-82.
  26. Raggi P., Chertow G., Urena Torres P. et al. The ADVANCE study: a randomized study to evaluate the effects of cinacalcet plus low-dose vitamin D on vascular calcification in patients with hemodialysis // Nephrol. Dial. Transplant. -2010; 26(4): 1327-39.
  27. Regidor M. Cinacalcet reduces vascular and soft tissue calcification in secondary hyperparathyroidism (SHPT) in hemodialysis patients // Clin. Nephrol. -2009; 71 (2): 207-13.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2012 Russkiy Vrach Publishing House

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies